GlycoMimetics Inc.

0.19
0.00 (2.65%)
At close: Apr 04, 2025, 10:25 AM

GlycoMimetics Statistics

Share Statistics

GlycoMimetics has 64.51M shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding 64.51M
Shares Change (YoY) 0.08%
Shares Change (QoQ) 0.05%
Owned by Institutions (%) 47.07%
Shares Floating 56.1M
Failed to Deliver (FTD) Shares 7.09K
FTD / Avg. Volume 0.51%

Short Selling Information

The latest short interest is 5.64M, so 8.74% of the outstanding shares have been sold short.

Short Interest 5.64M
Short % of Shares Out 8.74%
Short % of Float 9.88%
Short Ratio (days to cover) 1.07

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -2.8. GlycoMimetics's PEG ratio is 0.

PE Ratio 0
Forward PE -2.8
PS Ratio 0
Forward PS 0.8
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for GlycoMimetics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.01.

Current Ratio 1.92
Quick Ratio 1.92
Debt / Equity 0.01
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $0
Employee Count 4
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -92.99% in the last 52 weeks. The beta is 1.81, so GlycoMimetics's price volatility has been higher than the market average.

Beta 1.81
52-Week Price Change -92.99%
50-Day Moving Average 0.26
200-Day Moving Average 0.25
Relative Strength Index (RSI) 27.28
Average Volume (20 Days) 1.4M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -40.04B
Net Income 0
EBITDA -40.04B
EBIT n/a
Earnings Per Share (EPS) -0.59
Full Income Statement

Balance Sheet

The company has 10.72M in cash and 66.84M in debt, giving a net cash position of -56.12M.

Cash & Cash Equivalents 10.72M
Total Debt 66.84M
Net Cash -56.12M
Retained Earnings -494.36B
Total Assets 11.09M
Working Capital 5.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.1B and capital expenditures -9.97K, giving a free cash flow of -31.11B.

Operating Cash Flow -31.1B
Capital Expenditures -9.97K
Free Cash Flow -31.11B
FCF Per Share -482.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GLYC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for GLYC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -70.69
Piotroski F-Score 2